6 words from Pfizer CEO that cause problems for Moderna and BioNTech
[ad_1] BioNTech (NASDAQ: BNTX) recently got a public message of breaking up from her favorite collaboration partner that sounded with Modern (NASDAQ: ARNM) and all other biotechnologies with similar technology. Pfizer (NYSE: PFE) decided that they could make messenger RNA (mRNA) vaccines for other diseases without the help of BioNTech or anyone else. While boasting … Read more